leisure time -WSS

leisure time

author：entertainment 2025-10-01 21:47:36 - browse：616

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Readers discuss the intersection of pregnancy and addiction

hotspot

WSS

Moderna says combo Covid

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Change Healthcare payments predicted restored March 15

The system is set up to fail children with medical complexity

First medicine developed to treat MASH expected to be approved soon

Change Healthcare payments predicted restored March 15

leisure time

leisure time

leisure time

Anesthesiologist group: stop taking Ozempic before surgery

Pharma companies must ensure equitable access to obesity drugs

Jerome Adams on the need for new antivirals for Covid

First medicine developed to treat MASH expected to be approved soon

Trump demands the U.S. pay no more for drugs than other countries … again

Amylyx ALS drug fails large clinical trial

As demand for Covid shots wanes, Moderna seeks its next success

Curing rare childhood diseases will falter unless Congress steps up

Medical records are filled with copy

Air quality improving but still lags in Black, Hispanic communities

hotspot

Former medical device CEO who sold dummy, plastic parts convicted of fraud

CDC marks new Covid

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

NEJM study link tiny plastics in blood vessels to heart problems

NEJM study link tiny plastics in blood vessels to heart problems

ALS patient reclaims some autonomy thanks to wearable 'robot'

hotspot

hotspot

entertainment

entertainment